(1)
StanisicS.; BertolottoA.; BertoP.; Di ProcoloP.; MorawskiJ. The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy. GRHTA 2019, 6.